Premaitha Health PLC (LON:NIPT – Get Free Report) shares rose 2.2% during trading on Wednesday . The stock traded as high as GBX 9.10 ($0.11) and last traded at GBX 9.10 ($0.11). Approximately 1,571,557 shares were traded during trading, an increase of 17% from the average daily volume of 1,348,942 shares. The stock had previously closed at GBX 8.90 ($0.11).
Premaitha Health Stock Performance
The company has a 50 day simple moving average of GBX 9.10 and a 200 day simple moving average of GBX 9.10.
Premaitha Health Company Profile
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome.
Featured Articles
- Five stocks we like better than Premaitha Health
- Insider Trades May Not Tell You What You Think
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Why Are These Companies Considered Blue Chips?
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Bank Stocks – Best Bank Stocks to Invest In
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Premaitha Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premaitha Health and related companies with MarketBeat.com's FREE daily email newsletter.
